medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

Original research article

Predicting clinical outcome with phenotypic clusters in COVID-19 pneumonia:
an analysis of 12,066 hospitalized patients from the Spanish registry
SEMI-COVID-19.
Manuel Rubio-Rivas MD PhD 1*, Xavier Corbella MD PhD

, José María Mora-Luján MD 1, Jose

1,2**

Loureiro Amigo MD 3, Almudena López Sampalo MD 4, Carmen Yera Bergua MD 5, Pedro Jesús
Esteve Atiénzar MD PhD 6, Luis Felipe Díez García MD 7, Ruth Gonzalez Ferrer MD 8, Susana Plaza
Canteli MD 9, Antía Pérez Piñeiro MD 10, Begoña Cortés Rodríguez MD 11, Leyre Jorquer Vidal MD 12,
Ignacio Pérez Catalán MD

, Marta Leon Tellez MD 14, José Ángel Martín Oterino MD 15, María

13

Candelaria Martín González MD 16, José Luis Serrano Carrillo de Albornoz MD 17, Eva Garcia Sardon
MD 18, José Nicolás Alcalá Pedrajas MD 19, Anabel Martin-Urda Diez-Canseco MD 20, Mª José Esteban
Giner MD

, Pablo Tellería Gómez MD

21

Ramos-Rincón MD PhD

24

, Ricardo Gómez-Huelgas MD PhD

22

, José Manuel

23

; for the SEMI-COVID-19 Network***.

Affiliation 1: Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical
Research

Institute-IDIBELL,

University

of

Barcelona,

Barcelona,

Spain;

mrubio@bellvitgehospital.cat, xcorbella@bellvitgehospital.cat, jmora@bellvitgehospital.cat
Affiliation 2: Group of Evaluation of Health Determinants and Health Policies, Hestia Chair in
Integrated Health and Social Care, School of Medicine, Universitat Internacional de Catalunya,
Barcelona, Spain; xcorbella@bellvitgehospital.cat
Affiliation 3: Internal Medicine Department, Moisès Broggi Hospital, Sant Joan Despí, Barcelona,
Spain; ahores@gmail.com
Affiliation 4: Internal Medicine Department, Regional University Hospital of Málaga, Málaga, Spain;
almu_540@hotmail.com
Affiliation 5: Internal Medicine Department, Virgen de la Salud Hospital, Toledo, Spain;
mamenyera@hotmail.com
Affiliation 6: Internal Medicine Department, San Juan de Alicante University Hospital, San Juan de
Alicante (Alicante), Spain; pedroesteve82@gmail.com
Affiliation

7:

Internal

Medicine

Department,

Torrecárdenas

Hospital,

Almería,

Spain;

lfdiez@telefonica.net
Affiliation 8: Internal Medicine Department, Tajo Hospital, Aranjuez (Madrid), Spain;
ruthgferrer@gmail.com
Affiliation 9: Internal Medicine Department, Severo Ochoa University Hospital, Leganés (Madrid),
Spain; susana.plaza@salud.madrid.org
Affiliation 10: Internal Medicine Department, Valle del Nalón Hospital, Riaño (Langreo, Asturias),
Spain; antia.perez.pineiro@gmail.com
Affiliation 11: Internal Medicine Department, Alto Guadalquivir Hospital, Andújar (Jaén), Spain;
bcortes@ephag.es
Affiliation 12: Internal Medicine Department, Francesc de Borja Hospital, Gandia (Valencia), Spain;
leyrjorvi@gmail.com
Affiliation 13: Internal Medicine Department, Castellón General University Hospital, Castellón de la
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

Plana, Spain; nachocs13@gmail.com

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90

Affiliation

14:

Internal

Medicine

Department,

Santa

Bárbara

Hospital,

Soria,

Spain;

mleont@saludcastillayleon.es
Affiliation 15: Internal Medicine Department, Salamanca University Hospital Complex, Salamanca,
Spain; jmoterino@saludcastillayleon.es
Affiliation 16: Internal Medicine Department, Canarias University Hospital, Santa Cruz de Tenerife,
Spain; candemartin1983@gmail.com
Affiliation

17:

Internal

Medicine

Department,

Poniente

Hospital,

Almería,

Spain;

jlserranocarrillo@hotmail.com
Affiliation 18: Internal Medicine Department, San Pedro de Alcántara Hospital, Cáceres, Spain;
evagsardon@gmail.com
Affiliation 19: Internal Medicine Department, Pozoblanco Hospital, Pozoblanco (Córdoba), Spain;
jnalcala58@hotmail.com
Affiliation 20:

Internal Medicine Department, Palamós Hospital, Palamós (Girona), Spain;

anabelmartinurda10canseco@gmail.com
Affiliation 21: Internal Medicine Department, Virgen de los Lirios Hospital, Alcoy (Alicante), Spain;
mestebanginer@gmail.com
Affiliation 22: Internal Medicine Department, Valladolid Clinical University Hospital, Valladolid,
Spain; pablotelleria92@gmail.com
Affiliation 23: Internal Medicine Department, Regional University Hospital of Málaga. Instituto de
Investigación Biomédica de Málaga (IBIMA), Malaga, Spain; ricardogomezhuelgas@hotmail.com
Affiliation 24: Department of Clinical Medicine, Miguel Hernandez University of Elche (Alicante),
Spain; jramosrincon@yahoo.es
*

Correspondence: mrubio@bellvitgehospital.cat

**M. Rubio-Rivas and X. Corbella contributed equally as co-first authors of the study.
*** A complete list of the SEMI-COVID-19 Network members is provided in the Appendix.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122

Abstract: (1) Background: This study aims to identify different clinical phenotypes in COVID-19
pneumonia using cluster analysis and to assess the prognostic impact among identified clusters in
such patients. (2) Methods: Cluster analysis including 11 phenotypic variables was performed in a
large cohort of 12,066 COVID-19 patients, collected and followed-up from March 1, to July 31, 2020,
from the nationwide Spanish SEMI-COVID-19 Registry. (3) Results: Of the total of 12,066 patients
included in the study, most were males (7,052, 58.5%) and Caucasian (10,635, 89.5%), with a mean
age at diagnosis of 67 years (SD 16). The main pre-admission comorbidities were arterial
hypertension (6,030, 50%), hyperlipidemia (4,741, 39.4%) and diabetes mellitus (2,309, 19.2%). The
average number of days from COVID-19 symptom onset to hospital admission was 6.7 days (SD 7).
The triad of fever, cough, and dyspnea was present almost uniformly in all 4 clinical phenotypes
identified by clustering. Cluster C1 (8,737 patients, 72.4%) was the largest, and comprised patients
with the triad alone. Cluster C2 (1,196 patients, 9.9%) also presented with ageusia and anosmia;
cluster C3 (880 patients, 7.3%) also had arthromyalgia, headache, and sore throat; and cluster C4
(1,253 patients, 10.4%) also manifested with diarrhea, vomiting, and abdominal pain. Compared to
each other, cluster C1 presented the highest in-hospital mortality (24.1% vs. 4.3% vs. 14.7% vs. 18.6%;
p<0.001). The multivariate study identified phenotypic clusters as an independent factor for
in-hospital death. (4) Conclusion: The present study identified 4 phenotypic clusters in patients with
COVID-19 pneumonia, which predicted the in-hospital prognosis of clinical outcomes.
Keywords: COVID-19; Cluster analysis; Prognosis; Phenotype

1. Introduction
Since January 2020, the COVID-19 pneumonia pandemic has spread across the globe. As of
August 13th, 2020, 20,624,830 people have been infected worldwide and 749,424 people have died.
Numerous studies have highlighted the clinical characteristics of the disease [1-3]. From the
beginning, different clinical forms in presentation and prognosis have been intuited; however, these
clinical forms have not been defined yet. Although some factors associated with poor prognosis are
known [4], it is not clear which patients may present a worse evolution during hospitalization and
why.
The present study aimed to identify clinical phenotypes by cluster analysis in our large
nationwide series of COVID-19 pneumonia and to create a predictive model related to a poor
outcome.
2.

Materials and methods

123

2.1. Study Design, Patient Selection, and Data Collection

124
125
126
127
128
129
130
131

A cluster analysis was performed in the large cohort of consecutive patients included in the
Spanish registry SEMI-COVID-19, created by the Spanish Society of Internal Medicine (SEMI). This
is a multicenter, nationwide registry with 109 hospitals registered so far. From March 1, to July 31,
2020, 12,066 hospitalized patients providing data of symptoms of COVID-19 upon admission were
included in the Registry. All included patients were diagnosed by polymerase chain reaction (PCR)
test taken from a nasopharyngeal sample, sputum or bronchoalveolar lavage.
All participating centers in the register received confirmation from the relevant Ethics
Committees, including Bellvitge University Hospital (PR 128/20).

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

132

2.2. Treatments prescribed

133
134
135
136

The treatments received were in accordance with the medical guidelines available at the time of

137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172

the pandemic [5-11]. In the absence of clinical evidence of any of the treatments at the initial time of
the pandemic, their use was allowed off-label.
2.3. Outcomes definition
The primary outcome of the study was in-hospital mortality. The secondary outcome was the
requirement of mechanical ventilation or intensive care unit (ICU) admission.
2.4. Statistical analysis
Categorical variables were expressed as absolute numbers and percentages. Continuous
variables are expressed as mean plus standard deviation (SD) in case of parametric distribution or
median [IQR] in the case of non-parametric distribution. Differences among groups were assessed
using the chi-square test for categorical variable and ANOVA or Kruskal-Wallis test as appropriate
for continuous variables. P-values< 0.05 indicated statistical significance.
The cluster analysis was performed by ascendant hierarchical clustering on the 11 variables
previously selected by using Ward’s minimum variance method with Euclidean squared distance
[12]. Results are graphically depicted by a dendrogram. The number of clusters was estimated by a
visual distance criterion of the dendrogram. The cluster analysis model was included in a binary
logistic regression, taking the two above-mentioned outcomes as dependent variables. Mortality
among the groups was represented by the Kaplan-Meier curves with their logarithmic range test.
Statistical analysis was performed by IBM SPSS Statistics for Windows, Version 26.0. Armonk,
NY: IBM Corp.
3.

Results

3.1. General data and symptoms
A total of 12,066 patients were included in the study. General data of the whole cohort are
summarized in Table 1. Patients were mostly males (7,052, 58.5%) and Caucasian (10,635, 89.5%).
The mean age at diagnosis was 67 years (SD 16). The average number of days from symptom onset
to hospital admission was 6.7 days (SD 7). The main pre-admission comorbidities were arterial
hypertension (6,030, 50%), hyperlipidemia (4,741, 39.4%) and diabetes mellitus (2,309, 19.2%). The
mean Charlson index among patients was 1.2 (SD 1.8). The most common symptoms (Table 2) were
fever 10,346 (85.7%), cough (9,142, 75.8%), dyspnea (7,205, 59.7%), arthromyalgia (3,794, 31.4%),
diarrhea (2,943, 24. 4%), headache (1,402, 11.6%), sore throat (1,191, 9.9%), ageusia (992, 8.2%),
vomiting (891, 7.4%), anosmia (879, 7.3%), and abdominal pain (738, 6.1%).
3.2

Clustering analysis.

Despite most patients presenting with fever, cough, and/or dyspnea, 4 different clusters were
identified. The main characteristics of each are shown in Tables 1-5. Cluster C1 (8,737 patients,
72.4%) comprised patients with the triad of fever, cough, and dyspnea, with no other predominant
symptoms. Subjects grouped in cluster C1 tended to be elderly males with a higher prevalence of
comorbidities. The time between symptom onset and admission was also shorter in this subgroup of
patients, in comparison with the other identified clusters. One in ten C1 patients required ICU
admission and a quarter of them died, representing the highest mortality rate among the 4 clusters.
Patients in the C2 cluster (1,196 patients, 9.9%) comprised patients predominantly presenting with

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215

ageusia and/or anosmia, often accompanied by fever, cough, and/or dyspnea. Subjects grouped in
the C2 cluster showed the lowest percentage of ICU admission and mortality rate. Cluster C3 (880
patients, 7.3%) included patients predominantly with arthromyalgia, headache, and/or sore throat
presentations, often also accompanied by fever, cough, and/or dyspnea. Up to 9.7% of C3 patients
required ICU admission and 14.5% died. Finally, subjects grouped in cluster C4 (1,253 patients,
10.4%) presented predominantly with diarrhea, vomiting, and/or abdominal pain, also often
accompanied by fever, cough, and/or dyspnea. Of these, 8.5% required ICU admission and 18.6%
died. This mortality rate of cluster C4 was second only to the C1.
Analytical results among clusters showed that PaO2/FiO2 at entry was a median 286 mmHg
[229-338], being highest in the C2 cluster (281 mmHg vs. 305 vs. 295 vs. 295; p<0.001). Cluster C1
showed the highest values of C-reactive protein (CRP) (78 mg/l vs. 69 vs. 63 vs. 66; p<0.001), lactate
dehydrogenate (LDH) (332 U/l vs. 309 vs. 330 vs. 331; p<0.001), ferritin (669 mcg/l vs. 634 vs. 587 vs.
620; p=0.051), interleukin-6 (IL-6) (37 pg/ml vs. 26 vs. 27 vs. 24; p<0.001), and D-dimer (680 ng/ml vs.
594 vs. 595 vs. 608; p<0.001).
3.3 Treatments and outcomes
The treatments received are shown in Table 4. As antiviral treatment, patients were treated with
hydroxychloroquine (HCQ) (10,665, 88.6%), Lopinavir/ritonavir (LPV/r) (7,894, 65.7%), azithromycin
(7,558, 62.9%) and remdesivir (60, 0.5%). As immunomodulatory treatments, they received
corticosteroids (4,343, 36.2%), interferon (1,496, 12.5%) and tocilizumab (1,121, 9.3%). As
anticoagulant

treatment,

patients

received

oral

anticoagulation

(384,

3.18%)

or

low-molecular-weight heparin (LMWH) at prophylactic doses (7,903, 65.9%), intermediate doses
(815, 6.8%) or full doses (1,305, 10.9%).
Of the total 12,066, 1,038 (8.7%) patients required high-flow nasal cannula (HFNC), 641 (5.3%)
non-invasive mechanical ventilation (NIMV), and 906 (7.5%) invasive mechanical ventilation (IMV).
Admissions to the ICU numbered 1,120 patients (9.3%). Overall, the mortality rate was 20.9% (2,522
patients). The outcomes are shown in Table 5.
3.4 Predictive model for mortality
A predictive study of uni- and multivariate logistic regression using in-hospital death as a
dependent variable was performed. The predictors of mortality in the multivariate study were as
follows: age [OR 1.07 (1.04-1.11)], gender (female) [OR 0.24 (0.10-0.56)], BMI [OR 1.09 (1.02-1. 17)],
Charlson index [OR 1.52 (1.30-1.78)], respiratory rate upon admission >20 bpm [OR 2.84 (1.33-6.05)],
PaO2/FiO2 upon admission [OR 0.99 (0.98-1.00)], CRP [OR 0.99 (0.99-1.00)], LDH [OR 1.00
(1.00-1.00)], ferritin [OR 1.00 (1.00-1.00)], IL-6 [OR 1.00 (1.00-1.00)], and the phenotypic cluster. The
C1 cluster was chosen as a reference. Clusters C2 [OR 0.91 (0.30-2.31)] and C3 [OR 0.18 (0.04-0.96)]
had a better prognosis in the multivariate study. The C4 cluster was also observed to have a poor
prognosis [OR 2.85 (0.88-9.22)].

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

216
217

3.5 Figures, Tables and Schemes

218
219
220
221

(a)

222
223
224
225
226
227
228
229
230
231

Figure 1. Dendrogram.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

232
Table 1. General data between clusters
All patients

C1

C2

C3

C4

N=12,066

N=8,737

N=1,196

N=880

N=1,253

p-value

Age yr, median [IQR]

68 [56-79]

70 [57-80]

61 [51-71]

64 [52-75]

67 [53-77]

<0.001

Gender, males n (%)

7,052 (58.5)

5,303 (60.8)

643 (53.8)

507 (57.6)

599 (47.9)

<0.001

Caucasian

10,635 (89.5)

7,820 (90.9)

1,023 (86.7)

738 (84.7)

1,054 (86)

Black

43 (0.4)

35 (0.4)

3 (0.3)

1 (0.1)

4 (0.3)

Hispanic

1,041 (8.8)

643 (7.5)

137 (11.6)

117 (13.4)

144 (11.7)

Asian

59 (0.5)

41 (0.5)

2 (0.2)

6 (0.7)

10 (0.8)

Others

100 (0.8)

62 (9.7)

15 (1.3)

9 (1)

14 (1.1)

BMI, median [IQR]

28 [25-31]

28 [25-31]

28 [25-31]

28 [25-31]

28 [25-31]

0.426

Days from onset to admission, median [IQR]

7 [4-9]

6 [3-9]

8 [6-10]

7 [4-10]

7 [4-9]

<0.001

Never

8,035 (69.7)

5,761 (69.2)

793 (68.7)

587 (69.4)

894 (74.3)

Current smoker

567 (4.9)

414 (5)

64 (5.5)

41 (4.8)

48 (4)

Former smoker

2,930 (25.4)

2,153 (25.9)

297 (25.7)

218 (25.8)

262 (21.8)

Arterial hypertension

6,030 (50)

4,571 (52.4)

468 (39.1)

386 (43.9)

605 (48.4)

<0.001

Diabetes mellitus

2,309 (19.2)

1,774 (20.4)

177 (14.8)

156 (17.8)

202 (16.2)

<0.001

Hyperlipidemia

4,741 (39.4)

3,527 (40.4)

420 (35.1)

325 (37)

469 (37.5)

0.001

COPD

786 (6.5)

649 (7.4)

44 (3.7)

43 (4.9)

50 (4)

<0.001

Asthma

869 (7.2)

630 (7.2)

90 (7.5)

57 (6.5)

92 (7.4)

0.827

OSAS

751 (6.3)

574 (6.6)

57 (4.8)

48 (5.5)

72 (5.8)

0.057

Ischaemic cardiopathy

931 (7.7)

722 (8.3)

49 (4.1)

65 (7.4)

95 (7.6)

<0.001

Chronic heart failure

809 (6.7)

660 (7.6)

41 (3.4)

42 (4.8)

66 (5.3)

<0.001

Chronic kidney disease

696 (5.8)

550 (6.3)

36 (3)

36 (4.1)

74 (5.9)

<0.001

Chronic hepatopathy

440 (3.7)

330 (3.8)

46 (3.8)

22 (2.5)

42 (3.4)

<0.001

Active cancer

1,196 (9.9)

916 (10.5)

94 (7.9)

72 (8.2)

114 (9.1)

0.005

Autoimmune disease

277 (2.3)

195 (2.2)

33 (2.8)

19 (2.2)

30 (2.4)

0.701

1 [0-2]

1 [0-2]

0 [0-1]

0 [0-1]

0 [0-2]

<0.001

Race

<0.001

Smoking behaviour, n (%)

0.027

Comorbidity, n(%)

Charlson index, median [IQR]

BMI: body mass index. COPD: chronic obstructive pulmonary disease. OSAS: obstructive sleep apnea syndrome

233
234
235
236

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

237
Table 2. Symptoms and physical examination between clusters
All patients

C1

C2

C3

C4

N=12,066

N=8,737

N=1,196

N=880

N=1,253

p-value

Symptoms n(%)
High-grade fever ≥38º C

7,915 (65.6)

5,672 (64.9)

843 (70.5)

598 (68)

802 (64)

<0.001

Low-grade fever <38ºC

2,431 (20.1)

1,723 (19.7)

238 (19.9)

194 (22)

276 (22)

<0.001

Cough

9,142 (75.8)

6,501 (74.4)

993 (83)

766 (87)

882 (70.4)

<0.001

Dyspnea

7,205 (59.7)

5,340 (61.1)

727 (60.8)

492 (55.9)

646 (51.6)

<0.001

Arthromyalgia

3,794 (31.4)

2,432 (27.8)

569 (47.6)

370 (42)

423 (33.8)

<0.001

Sore throat

1,191 (9.9)

0

186 (15.6)

880 (100)

125 (10)

<0.001

Headache

1,402 (11,6)

730 (8.4)

292 (24.4)

202 (23)

178 (14.2)

<0.001

Anosmia

879 (7.3)

0

879 (73.5)

0

0

<0.001

Ageusia

992 (8.2)

0

988 (82.6)

0

4 (0.3)

<0.001

Diarrhea

2,943 (24.4)

1,654 (18.9)

473 (39.5)

181 (20.6)

635 (50.7)

<0.001

Vomiting

891 (7.4)

0

110 (9.2)

0

781 (62.3)

<0.001

Abdominal pain

738 (6.1)

0

79 (6.6)

0

659 (52.6)

<0.001

Heart rate upon admission, bpm median [IQR]

88 [77-100]

87 [76-100]

89 [79-100]

89 [78-100]

87 [77-100]

0.001

Respiratory rate upon admission >20x’, n(%)

3,833 (32.5)

2,939 (34.4)

304 (26.1)

249 (28.9)

341 (28)

<0.001

238
Table 3. Lab tests between clusters
All patients

C1

C2

C3

C4

N=12,066

N=8,737

N=1,196

N=880

N=1,253

286 [229-338]

281 [224-333]

305 [254-355]

295 [238-352]

295 [238-348]

<0.001

Lymphocytes x106/l

910 [680-1,280]

900 [660-1,270]

1,000 [700-1,310]

1,000 [715-1,300]

900 [630-1,210]

<0.001

CRP mg/l

74 [30-141]

78 [30-146]

69 [29-130]

63 [26-135]

66 [27-129]

<0.001

LDH U/l

329 [253-444]

332 [255-450]

309 [247-412]

330 [248-446]

331 [256-439]

<0.001

ALT U/l

30 [19-47]

29 [19-46]

32 [21-52]

31 [21-49]

30 [20-48]

<0.001

Ferritin mcg/l

655 [324-1,281]

669 [330-1,320]

634 [291-1,172]

587 [310-1,167]

620 [326-1,265]

0.051

IL6 pg/ml

33 [13-69]

37 [14-73]

26 [9-54]

27 [12-70]

24 [10-58]

<0.001

D-dimer ng/ml

654 [370-1,204]

680 [382-1,290]

594 [346-980]

595 [347-1,023]

608 [350-1,152]

<0.001

PaO2/FiO2

upon

admission,

mmHg

p-value

median [IQR]
Lab test upon admission, median [IQR]

ALT: alanine transaminase. CRP: C-reactive protein. IL6: interleukin6. LDH: lactate dehydrogenase

239

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

240
241

Table 4. Treatments between clusters
All

C1

C2

C3

C4

p-value

patients

N=8,737

N=1,196

N=880

N=1,253

N=12,066
HCQ, n (%)

10,665

7,654 (87.9)

1,130 (94.5)

770 (87.6)

1,111 (88.8)

<0.001

LPV/r, n (%)

(88.6)

5,640 (64.8)

783 (65.5)

610 (69.5)

861 (69)

0.002

Azithromicin, n (%)

7,894 (65.7)

5,407 (62.2)

835 (69.8)

510 (58)

806 (64.5)

<0.001

Remdesivir, n (%)

7,558 (62.9)

36 (0.4)

10 (0.8)

5 (0.6)

9 (0.7)

0.150

60 (0.5)
Interferon, n (%)

1,496 (12,5)

1,122 (13)

68 (5.7)

141 (16.1)

165 (13.2)

<0.001

Tocilizumab, n (%)

1,121 (9.3)

810 (9.3)

110 (9.2)

93 (10.6)

108 (8.7)

0.487

Corticosteroids, n (%)

4,343 (36.2)

3,254 (37.5)

399 (33.5)

273 (31.2)

417 (33.4)

<0.001

Heparin, n (%)

<0.001

Prophylactic LMWH

7,903 (65.9)

5,633 (65)

817 (68.5)

584 (66.6)

869 (69.7)

Middle doses LMWH

815 (6.8)

589 (6.8)

97 (8.1)

49 (5.6)

80 (6.4)

High doses LMWH

1,305 (10.9)

997 (11.5)

120 (10.1)

90 (10.3)

98 (7.9)

Oral anticoagulation, n (%)

0.004

Oral anti-vitamin K drugs

189 (1.6)

156 (1.8)

10 (0.8)

7 (0.8)

16 (1.3)

DOACs

195 (1.6)

157 (1.8)

10 (0.8)

10 (1.1)

18 (1.4)

DOACs: direct oral anticoagulants. HCQ: hydroxychloroquine. LPV/r: lopinavir/ritonavir. LMWH: low-molecular weight heparin

242
243

Table 5. Outcomes between clusters
All patients

C1

C2

C3

C4

N=12,066

N=8,737

N=1,196

N=880

N=1,253

p-value

Oxygenation/ventilation, n (%)
HFNC

1,038 (8.7)

757 (8.8)

82 (6.9)

75 (8.5)

124 (10)

0.053

NIMV

641 (5.3)

485 (5.6)

46 (3.9)

44 (5)

66 (5.3)

0.094

IMV

906 (7.5)

694 (8)

49 (4.1)

75 (8.6)

88 (7.1)

<0.001

ICU admission, n (%)

1,120 (9.3)

847 (9.7)

71 (5.9)

95 (10.8)

107 (8.5)

<0.001

Death, n (%)

2,522 (20.9)

2,109 (24.1)

51 (4.3)

129 (14.7)

233 (18.6)

<0.001

HFNC: high-flow nasal cannula. ICU: intensive care unit. IMV: invasive mechanical ventilation. NIMV: non-invasive mechanical ventilation.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

244

Table 6. Risk factors of in-hospital mortality.
Univariate analysis

p-value

Multivariate

OR (95%CI)

p-value

analysis
OR (95%CI)

Age/year

1.09 (1.09-1.10)

<0.001

1.07 (1.04-1.11)

<0.001

Gender (female)

0.78 (0.71-0.86)

<0.001

0.24 (0.10-0.56)

0.001

BMI

1.02 (1.01-1.04)

<0.001

1.09 (1.02-1.17)

0.014

Arterial hypertension

3.07 (2.79-3.38)

<0.001

NS

Diabetes mellitus

2.07 (1.87-2.29)

<0.001

NS

Hyperlipidemia

1.80 (1.64-1.96)

<0.001

NS

COPD

2.82 (2.43-3.27)

<0.001

NS

Ischaemic cardiopathy

2.67 (2.32-3.07)

<0.001

NS

Chronic heart failure

3.74 (3.23-4.32)

<0.001

NS

Chronic kidney disease

3.18 (2.72-3.72)

<0.001

NS

Chronic hepatopathy

1.57 (1.27-1.94)

<0.001

NS

Active cancer

2.23 (1.96-2.53)

<0.001

NS

Charlson index

1.37 (1.34-1.41)

<0.001

1.52 (1.30-1.78)

<0.001

Heart rate upon admission

1.00 (0.99-1.00)

0.278

Respiratory rate upon admission >20x’

4.48 (4.08-4.92)

<0.001

2.84 (1.33-6.05)

0.007

PaO2/FiO2 upon admission

0.99 (0.99-0.99)

<0.001

0.99 (0.98-1.00)

0.001

Lymphocytes x106/l

1.00 (1.00-1.00)

0.768

CRP mg/l

1.01 (1.01.1.01)

<0.001

0.99 (0.99-1.00)

0.034

LDH U/l

1.00 (1.00-1.00)

<0.001

1.00 (1.00-1.00)

0.032

ALT U/l

1.00 (0.99-1.00)

0.792

Ferritin mcg/l

1.00 (1.00-1.00)

<0.001

1.00 (1.00-1.00)

0.001

IL6 pg/ml

1.00 (1.00-1.00)

<0.001

1.00 (1.00-1.00)

0.020

D-dimer ng/ml

1.00 (1.00-1.00)

<0.001

1.00 (1.00-1.00)

0.054

Remdesivir

1.16 (0.64-2.12)

0.623

Tocilizumab

1.24 (1.07-1.43)

0.004

NS

Corticosteroids

2.06 (1.89-2.26)

<0.001

NS

Comorbidity

Lab test upon admission

Treatments during admission

Clusters
C1

1 ref.

1 ref.

C2

0.14 (0.11-0.19)

<0.001

0.91 (0.30-2.75)

0.865

C3

0.54 (0.45-0.66)

<0.001

0.18 (0.04-0.96)

0.044

C4

0.72 (0.62-0.84)

<0.001

2.85 (0.88-9.22)

0.082

BMI: body mass index. COPD: chronic obstructive pulmonary disease.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

245
246
247
248
249
250
251

Figure 2. In-hospital mortality between clusters. Kaplan-Meier. Log-rank test p<0.001

252
253
254

4.

255
256
257
258
259
260
261
262
263
264
265
266

The present investigation shows data from the first study of phenotypic clusters in COVID-19

Discussion

pneumonia. The source of data was the Spanish registry SEMI-COVID-19, whose characteristics
have recently been published [13]. Our analysis showed the existence of 4 clusters with
differentiated clinical peculiarities and different prognoses.
The general characteristics of age, gender, and comorbidities found in our study are consistent
with those already described in the literature. Likewise, the treatments administered are in
accordance with the study period covered by the record.
The triad of fever, cough, and dyspnea was present almost uniformly in all patients with
COVID-19 pneumonia grouped in the 4 phenotypes. However, other particular symptoms may help
clinicians to differentiate them. Cluster C1 does not usually present symptoms in addition to the
triad of fever, cough, and dyspnea. Subjects grouped in the C2 cluster usually present with ageusia
and/or anosmia in addition to the triad. Cluster C3 is characterized by the presence of concomitant

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308

arthromyalgia, headache, and/or sore throat. Finally, the C4 cluster also manifests with digestive
symptoms such as diarrhea, vomiting, and/or abdominal pain.
In terms of prognosis, the C1 cluster showed the highest mortality rate (24.1%) in this large
Spanish nation-wide series. It was followed by C4 (18.6%), C3 (14.7%), and finally C2 (4.3%). The
crude survival study identified the C2 cluster as a cluster of good prognosis. The multivariate
regression study showed a non-significative trend to better prognosis. Also identified the C3 cluster
as another good prognostic subgroup, in addition to C2. In contrast, the C1 and C4 clusters were
identified as the poorest prognosis clusters.
The risk factors recognized so far for poor prognosis have been repeated in several studies. The
mainly reported risk factors are advanced age, male gender, higher BMI, and some analytical
parameters such as PaO2/FiO2, lymphocyte count, CRP, LDH, ferritin, IL-6, and D-dimer. Certain
comorbidities such as diabetes mellitus, arterial hypertension, or hyperlipidemia have also been
suggested as poor prognostic factors but not identified to date.
Interestingly, the study presented here identifies the cluster phenotype as a new prognostic
factor. Since clusters share common characteristics, sometimes it can be difficult to recognize which
cluster a patient belongs to. However, in other many occasions, the clinical profile may be
sufficiently evident to recognize the cluster, helping physicians to make clinical decisions based on
prognostic information of the identified cluster.
To date, there are no published, peer-reviewed phenotypic cluster studies in the medical
literature on COVID-19. A study of clusters in out-of-hospital population can be found in the
medRxiv repository [14]. It is based on an app in which patients enter their symptoms. With these
data and some other clinical data provided by the patient, a risk of respiratory support (defined as
the need for oxygen therapy or mechanical ventilation) is deduced. It is therefore a predictor of
hospitalization, we could say. We have some doubts as to whether the source of the data can be
considered reliable since the data is not introduced by a doctor but by the patient himself. On the
other hand, the fact that it is based on an app may represent a bias against the elderly population not
accustomed to electronic devices. They identify 6 phenotypic clusters, with some similarity and
overlap with the clusters presented in our study. It is an interesting tool, specially designed for
general practitioners.
As for the generalization of our results, it should be noted that the data come from a developed
European western country with a mostly Caucasian population and little representation of other
ethnicities. Furthermore, it should also be taken into account that Spain has a universal-coverage
public healthcare system, not comparable with some other developed and developing countries. On
the other hand, proportionally speaking, Spain has one of the largest elderly populations in the
world and, as is well known, age has been described as a fundamental factor in the poor prognosis of
COVID-19 pneumonia [4]. These characteristics could influence the outcomes shown.
In order to speak properly, the definition of a true phenotype requires a consistent natural
history, similar clinical and physiological characteristics, underlying pathobiology with identifiable
biomarkers and genetics, and predictable response to general and specific therapies [15].
Accordingly, it would be necessary to study each of the present clinical clusters genetically and to
verify that each cluster has a differentiated genetic background. In the literature, some studies
attempted to phenotype patients with COVID-19 as a function of the immune response, and others

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

309
310
311
312
313
314
315
316
317
318
319
320
321
322

suggested phenotyping as a function of pathophysiology [16,17]. It would be interesting to combine

323
324
325
326
327
328
329
330
331
332

In conclusion, the present study identified 4 phenotypic clusters that predicted in-hospital

all methods of phenotyping.
We believe that the identification of the present clusters may be of great help to clinicians in
order to identify those cases with a better or worse prognosis, and thus direct more individualized
therapeutic strategies. In this regard, we also believe that identification of phenotypes can serve as a
guide for clinical trials, not evaluating new treatments in general, since not all subgroups of
COVID-19 patients may benefit from the same therapeutic strategies. On the other hand, drugs
previously discarded, but with a rational pathophysiological basis to be tested, should be reanalyzed
to clarify their real efficacy, taking into account the different clinical spectrum of COVID-19 patients.
The main strength of this study is the identification of different phenotypic clusters in COVID-19
pneumonia from a very large sample of more than 12,000 patients from more than 100 hospitals.
Among limitations, data were obtained from a retrospective register of a sole country, which means
that some specific data could be missing or collected with some grade of heterogeneity.
5.

Conclusions

prognosis of clinical outcome in a large nationwide series of patients with COVID-19 pneumonia.
Clusters associated with bad in-hospital prognosis were C1, in which subjects presented with the
isolated triad of fever, cough, and dyspnea, and C4 also manifested with diarrhea, vomiting, and/or
abdominal pain. In contrast, subjects grouped in the C2 cluster (manifested also with ageusia and/or
anosmia) showed the best prognosis, together with cluster C3 (adding arthromyalgia, headache,
and/or sore throat), which was second only to C2 showing a good outcome.

Acknowledgments

333
334
335
336
337

We gratefully acknowledge all the investigators who participate in the SEMI-COVID-19 Registry.

338
339
340
341
342
343
344
345
346
347
348

Author Contributions: For research articles with several authors, a short paragraph specifying their
individual contributions must be provided. The following statements should be used
“Conceptualization, M.R.-R., X.C and J.M. M.-L.; methodology, M.R.; software, M.R.; validation,
M.R.-R., X.C.; formal analysis, M.R.-R.; investigation, M.R.-R., X.C.; resources, R.G.-H., J.M.R.-R.;
data curation, M.R.-R., X.C, J.M. M.-L., J.L.A., A.L.S., C.Y.B., V.G.G., L.F.D.G., R.G.F., S.P.C., S.F.C.,
B.C.R., L.J.V., I.P.C., M.L.T., J.A.M.O., M.C.M.G., J.L.S.C., E.G.S., J.N.A.P., A.M.-U.D.-C., M.J.E.G.,
P.T.G., R.G.-H., J.M.R.-R.; writing—original draft preparation, M.R.-R., X.C.; writing—review and
editing, M.R.-R., X.C.; visualization M.R.-R., X.C.; supervision, M.R.-R., X.C, R.G.-H., J.M.R.-R.;
project administration, J.M.R.-R. All authors have read and agreed to the published version of the
manuscript.”, please turn to the CRediT taxonomy for the term explanation. Authorship must be
limited to those who have contributed substantially to the work reported.

We also thank the SEMI-COVID-19 Registry Coordinating Center, S&H Medical Science Service, for
their quality control data, logistic and administrative support. The authors declare that there are no
conflicts of interest.

349
350

Funding: This research received no external funding

351

Conflicts of Interest: The authors declare no conflict of interest.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

352

References

353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377

1.

378
379

10. Morena V, Milazzo L, Oreni L et al. Off-label use of tocilizumab for the treatment of

380
381
382

11. A RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in

383
384
385

12. Husson F, Josse J, Pagès J. Principal component methods – hierarchical clustering –

386
387
388
389

13. J M Casas-Rojo, J M Antón-Santos, J Millán-Núñez-Cortés, et al. Características clínicas de

Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients
with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62.

2.

Novel

Coronavirus

Pneumonia

Emergency

Response

Epidemiology

Team.

The

Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases
(COVID-19)

-

China,

2020.

China

CDC

http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51.

Weekly.
Accessed

March 12, 2020.
3.

Grasselli G, Zangrillo A, Zanella A et al. Baseline Characteristics and Outcomes of 1591
Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA
2020; 323: 1574-81.

4.

Du RH, Liang LR, Yang CQ et al. Predictors of Mortality for Patients with COVID-19
Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study. Eur Respir J. 2020; 55:
2000524.

5.

Gautret P, Cagier JC, Parola P et al. Hydroxychloroquine and azithromycin as a treatment of
COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents
2020: 105949.

6.

Cao B, Wang Y, Wen D et al. A Trial of Lopinavir-Ritonavir in adults hospitalized with
severe Covid-19. N Engl J Med 2020; 382: 1787-99.

7.

Grein J, Ohmagari N, Shin D et al. Compassionate Use of Remdesivir for Patients with
Severe Covid-19. N Engl J Med. April 2020; 382: e101.

8.

Capra R, De Rossi N, Mattioli F et al. Impact of low dose tocilizumab on mortality rate in
patients with COVID-19 related pneumonia. Eur J Intern Med 2020; 76: 31-5.

9.

Campochiaro C, Della-Torre E, Cavalli G et al.. Efficacy and safety of tocilizumab in severe
COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med 2020; 76:
43-9.

SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med 2020; 76: 36-42.

Hospitalized Patients with Covid-19 - Preliminary Report [published online ahead of print,
2020 Jul 17]. N Engl J Med. 2020;NEJMoa2021436. doi:10.1056/NEJMoa2021436

partitional clustering: why would we need to choose for visualizing data? Technical Report.
2010. http://math.agrocampus-ouest.fr/infoglueDeliverLive.

los pacientes hospitalizados con COVID-19 en España: resultados del Registro
SEMI-COVID-19.

Rev

Clin

https://doi.org/10.1016/j.rce.2020.07.003)

Esp

2020;

S0014-2565(20)30206-X.

(DOI:

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

390
391
392

14. Sudre CH, Lee K, Lochlainn MN, et al. Symptom clusters in Covid19: A potential clinical

393
394

15. Haldar P, Berair R. Endotypes and asthma. In: Bernstein JS, Levy M, editors. Clinical

395
396
397

16. Zhang

398
399
400

17. Cherian R, Chandra B, Tung ML, Vuylsteke A. COVID-19 conundrum: Clinical phenotyping

prediction tool from the COVID Symptom study app. medRxiv 2020.06.12.20129056; doi:
https://doi.org/10.1101/2020.06.12.20129056

asthma. Theory and practice. Boca Raton: CRC Press. 2014: 39-43.
B,

Zhou

X,

Zhu

C,

et

al.

Immune

Phenotyping

Based

on

the

Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for
Patients With COVID-19. Front Mol Biosci. 2020; 7: 157. doi: 10.3389/fmolb.2020.00157

based on pathophysiology as a promising approach to guide therapy in a novel illness. Eur
Respir J. 2020:2002135. doi: 10.1183/13993003.02135-2020

401
© 2020 by the authors. Submitted for possible open access publication under the terms
and conditions of the Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/).

402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460

Appendix. List of the SEMI-COVID-19 Network members
Coordinator of the SEMI-COVID-19 Registry: José Manuel Casas Rojo.
SEMI-COVID-19 Scientific Committee Members: José Manuel Casas Rojo, José Manuel Ramos
Rincón, Carlos Lumbreras Bermejo, Jesús Millán Núñez-Cortés, Juan Miguel Antón Santos, Ricardo
Gómez Huelgas.
SEMI-COVID-19 Registry Coordinating Center: S & H Medical Science Service.
Members of the SEMI-COVID-19 Group
H. U. 12 de Octubre. Madrid
Paloma Agudo de Blas, Coral Arévalo Cañas, Blanca Ayuso, José Bascuñana Morejón, Samara
Campos Escudero, María Carnevali Frías, Santiago Cossio Tejido, Borja de Miguel Campo, Carmen
Díaz Pedroche, Raquel Diaz Simon, Ana García Reyne, Lucia Jorge Huerta, Antonio Lalueza Blanco,
Jaime Laureiro Gonzalo, Carlos Lumbreras Bermejo, Guillermo Maestro de la Calle, Barbara Otero
Perpiña, Diana Paredes Ruiz, Marcos Sánchez Fernández, Javier Tejada Montes.
H. U. Gregorio Marañón. Madrid
Laura Abarca Casas, Álvaro Alejandre de Oña, Rubén Alonso Beato, Leyre Alonso Gonzalo, Jaime
Alonso Muñoz, Crhistian Mario Amodeo Oblitas, Cristina Ausín García, Marta Bacete Cebrián, Jesús
Baltasar Corral, Maria Barrientos Guerrero, Alejandro Bendala Estrada, María Calderón Moreno,
Paula Carrascosa Fernández, Raquel Carrillo, Sabela Castañeda Pérez, Eva Cervilla Muñoz, Agustín
Diego Chacón Moreno, Maria Carmen Cuenca Carvajal, Sergio de Santos, Andrés Enríquez Gómez,
Eduardo Fernández Carracedo, María Mercedes Ferreiro-Mazón Jenaro, Francisco Galeano Valle,
Alejandra Garcia, Irene Garcia Fernandez-Bravo, María Eugenia García Leoni, Maria Gomez
Antunez, Candela González San Narciso, Anthony Alexander Gurjian, Lorena Jiménez Ibáñez,
Cristina Lavilla Olleros, Cristina Llamazares Mendo, Sara Luis García, Víctor Mato Jimeno, Clara
Millán Nohales, Jesús Millán Núñez-Cortés, Sergio Moragón Ledesma, Antonio Muiño Miguez,
Cecilia Muñoz Delgado, Lucía Ordieres Ortega, Susana Pardo Sánchez, Alejandro Parra Virto, María
Teresa

Pérez

Sanz,

Blanca

Pinilla

Llorente,

Sandra

Piqueras

Ruiz,

Guillermo

Soria

Fernández-Llamazares, María Toledano Macías, Neera Toledo Samaniego, Ana Torres do Rego,
Maria Victoria Villalba Garcia, Gracia Villarreal, María Zurita Etayo.
Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat
Xavier Corbella, Narcís Homs, Abelardo Montero, Jose María Mora-Luján, Manuel Rubio-Rivas.
H. U. La Paz-Cantoblanco-Carlos III. Madrid
Jorge Álvarez Troncoso, Francisco Arnalich Fernández, Francisco Blanco Quintana, Carmen Busca
Arenzana, Sergio Carrasco Molina, Aranzazu Castellano Candalija, Germán Daroca Bengoa,
Alejandro de Gea Grela, Alicia de Lorenzo Hernández, Alejandro Díez Vidal, Carmen Fernández

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501

Capitán, Maria Francisca García Iglesias, Borja González Muñoz, Carmen Rosario Herrero Gil, Juan
María Herrero Martínez, Víctor Hontañón, Maria Jesús Jaras Hernández, Carlos Lahoz, Cristina
Marcelo Calvo, Juan Carlos Martín Gutiérrez, Monica Martinez Prieto, Elena Martínez Robles,
Araceli Menéndez Saldaña, Alberto Moreno Fernández, Jose Maria Mostaza Prieto, Ana Noblejas
Mozo, Carlos Manuel Oñoro López, Esmeralda Palmier Peláez, Marina Palomar Pampyn, Maria
Angustias Quesada Simón, Juan Carlos Ramos Ramos, Luis Ramos Ruperto, Aquilino Sánchez
Purificación, Teresa Sancho Bueso, Raquel Sorriguieta Torre, Clara Itziar Soto Abanedes, Yeray
Untoria Tabares, Marta Varas Mayoral, Julia Vásquez Manau.
C. H. U. de Albacete. Albacete
Jose Luis Beato Pérez, Maria Lourdes Sáez Méndez.
Complejo Asistencial de Segovia. Segovia
Eva María Ferreira Pasos, Daniel Monge Monge, Alba Varela García.
H. U. Puerta de Hierro. Majadahonda
María Álvarez Bello, Ane Andrés Eisenhofer, Ana Arias Milla, Isolina Baños Pérez, Javier Bilbao
Garay, Silvia Blanco Alonso, Jorge Calderón Parra, Alejandro Callejas Díaz, José María Camino
Salvador, Mª Cruz Carreño Hernández, Valentín Cuervas-Mons Martínez, Sara de la Fuente Moral,
Miguel del Pino Jimenez, Alberto Díaz de Santiago, Itziar Diego Yagüe, Ignacio Donate Velasco, Ana
María Duca, Pedro Durán del Campo, Gabriela Escudero López, Esther Expósito Palomo, Ana
Fernández Cruz, Esther Fiz Benito, Andrea Fraile López, Amy Galán Gómez, Sonia García Prieto,
Claudia García Rodríguez-Maimón, Miguel Ángel García Viejo, Javier Gómez Irusta, Edith Vanessa
Gutiérrez Abreu, Isabel Gutiérrez Martín, Ángela Gutiérrez Rojas, Andrea Gutiérrez Villanueva,
Jesús Herráiz Jiménez, Pedro Laguna del Estal, Mª Carmen Máinez Sáiz, Cristina Martín Martín,
María Martínez Urbistondo, Fernando Martínez Vera, Susana Mellor Pita, Patricia Mills Sánchez,
Esther Montero Hernández, Alberto Mora Vargas, Cristina Moreno López, Alfonso Ángel-Moreno
Maroto, Victor Moreno-Torres Concha, Ignacio Morrás De La Torre, Elena Múñez Rubio, Ana
Muñoz Gómez, Rosa Muñoz de Benito, Alejandro Muñoz Serrano, Jose María Palau Fayós, Ilduara
Pintos Pascual, Antonio Ramos Martínez, Isabel Redondo Cánovas del Castillo, Alberto Roldán
Montaud, Lucía Romero Imaz, Yolanda Romero Pizarro, Mónica Sánchez Santiuste, David Sánchez
Órtiz, Enrique Sánchez Chica, Patricia Serrano de la Fuente, Pablo Tutor de Ureta, Ángela Valencia
Alijo, Mercedes Valentín-Pastrana Aguilar, Juan Antonio Vargas Núñez, Jose Manuel Vázquez
Comendador, Gema Vázquez Contreras, Carmen Vizoso Gálvez.
H. Miguel Servet. Zaragoza
Gonzalo Acebes Repiso, Uxua Asín Samper, María Aranzazu Caudevilla Martínez, José Miguel
García Bruñén, Rosa García Fenoll, Jesús Javier González Igual, Laura Letona Giménez, Mónica
Llorente Barrio, Luis Sáez Comet.
H. U. La Princesa. Madrid

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543

María Aguilera García, Ester Alonso Monge, Jesús Álvarez Rodríguez, Claudia Alvarez Varela,
Miquel Berniz Gòdia, Marta Briega Molina, Marta Bustamante Vega, Jose Curbelo, Alicia de las
Heras Moreno, Ignacio Descalzo Godoy, Alexia Constanza Espiño Alvarez, Ignacio Fernández
Martín-Caro, Alejandra Franquet López-Mosteiro, Gonzalo Galvez Marquez, María J. García Blanco,
Yaiza García del Álamo Hernández, Clara García-Rayo Encina, Noemí Gilabert González, Carolina
Guillamo Rodríguez, Nicolás Labrador San Martín, Manuel Molina Báez, Carmen Muñoz Delgado,
Pedro Parra Caballero, Javier Pérez Serrano, Laura Rabes Rodríguez, Pablo Rodríguez Cortés, Carlos
Rodriguez Franco, Emilia Roy-Vallejo, Monica Rueda Vega, Aresio Sancha Lloret, Beatriz Sánchez
Moreno, Marta Sanz Alba, Jorge Serrano Ballester, Alba Somovilla, Carmen Suarez Fernández,
Macarena Vargas Tirado, Almudena Villa Marti.
H. U. de A Coruña. A Coruña
Alicia Alonso Álvarez, Olaya Alonso Juarros, Ariadna Arévalo López, Carmen Casariego Castiñeira,
Ana Cerezales Calviño, Marta Contreras Sánchez, Ramón Fernández Varela, Santiago J. Freire
Castro, Ana Padín Trigo, Rafael Prieto Jarel, Fátima Raad Varea, Laura Ramos Alonso, Francisco
Javier Sanmartín Pensado, David Vieito Porto.
H. Clínico San Carlos. Madrid
Inés Armenteros Yeguas, Javier Azaña Gómez, Julia Barrado Cuchillo, Irene Burruezo López, Noemí
Cabello Clotet, Alberto E. Calvo Elías, Elpidio Calvo Manuel, Carmen María Cano de Luque,
Cynthia Chocron Benbunan, Laura Dans Vilan, Ester Emilia Dubon Peralta, Vicente Estrada Pérez,
Santiago Fernandez-Castelao, Marcos Oliver Fragiel Saavedra, José Luis García Klepzig, Maria del
Rosario Iguarán Bermúdez, Esther Jaén Ferrer, Rubén Ángel Martín Sánchez, Manuel Méndez
Bailón, Maria José Nuñez Orantos, Carolina Olmos Mata, Eva Orviz García, David Oteo Mata,
Cristina Outon González, Juncal Perez-Somarriba, Pablo Pérez Mateos, Maria Esther Ramos Muñoz,
Xabier Rivas Regaira, Iñigo Sagastagoitia Fornie, Alejandro Salinas Botrán, Miguel Suárez Robles,
Maddalena Elena Urbano, Miguel Villar Martínez.
H. Infanta Sofía. S. S. de los Reyes
Rafael del Castillo Cantero, Rebeca Fuerte Martínez, Arturo Muñoz Blanco, José Francisco Pascual
Pareja, Isabel Perales Fraile, Isabel Rábago Lorite, Llanos Soler Rangel, Inés Suárez García, Jose Luis
Valle López.
Hospital Royo Villanova. Zaragoza
Nicolás Alcalá Rivera, Anxela Crestelo Vieitez, Esther del Corral, Jesús Díez Manglano, Isabel Fiteni
Mera, Maria del Mar Garcia Andreu, Martin Gerico Aseguinolaza, Claudia Josa Laorden, Raul
Martinez Murgui, Marta Teresa Matía Sanz.
H. Moisès Broggi. Sant Joan Despí
Judit Aranda Lobo, Jose Loureiro Amigo, Isabel Oriol Bermúdez, Melani Pestaña Fernández, Nicolas
Rhyman, Nuria Vázquez Piqueras.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584

Hospital Universitario Dr. Peset. Valencia
Juan Alberto Aguilera Ayllón, Arturo Artero, María del Mar Carmona Martín, María José Fabiá
Valls, Maria de Mar Fernández Garcés, Ana Belén Gómez Belda, Ian López Cruz, Manuel Madrazo
López, Elisabet Mateo Sanchis, Jaume Micó Gandia, Laura Piles Roger, Adela Maria Pina Belmonte,
Alba Viana García.
Hospital Clínico de Santiago. Santiago de Compostela
Maria del Carmen Beceiro Abad, Maria Aurora Freire Romero, Sonia Molinos Castro, Emilio Manuel
Paez Guillan, María Pazo Nuñez, Paula Maria Pesqueira Fontan.
H. Nuestra Señora del Prado. Talavera de la Reina
Sonia Casallo Blanco, Jeffrey Oskar Magallanes Gamboa.
H. U. Ramón y Cajal. Madrid
Luis Fernando

Abrego Vaca, Ana Andréu Arnanz, Octavio Arce García, Marta Bajo González,

Pablo Borque Sanz, Alberto Cozar Llisto, Sonia de Pedro Baena, Beatriz Del Hoyo Cuenda, María
Alejandra Gamboa Osorio, Isabel García Sánchez, Andrés González García, Oscar Alberto López
Cisneros, Miguel Martínez Lacalzada, Borja Merino Ortiz, Jimena Rey-García, Elisa Riera González,
Cristina Sánchez Díaz, Grisell Starita Fajardo, Cecilia Suárez Carantoña, Adrian Viteri Noel,
Svetlana Zhilina Zhilina.
H. U. Infanta Cristina. Parla
Juan Miguel Antón Santos, Ana Belén Barbero Barrera, Coralia Bueno Muiño, Ruth Calderón
Hernaiz, Irene Casado Lopez, José Manuel Casas Rojo, Andrés Cortés Troncoso, Mayte de Guzmán
García-Monge, Francesco Deodati, Gonzalo García Casasola Sánchez, Elena Garcia Guijarro, Davide
Luordo, María Mateos González, Jose A Melero Bermejo, Lorea Roteta García, Elena Sierra Gonzalo,
Javier Villanueva Martínez.
H. de Cabueñes. Gijón
Ana María Álvarez Suárez, Carlos Delgado Vergés, Rosa Fernandez-Madera Martínez, Eva Fonseca
Aizpuru, Alejandro Gómez Carrasco, Cristina Helguera Amezua, Juan Francisco López Caleya,
María del Mar Martínez López, Aleida Martínez Zapico, Carmen Olabuenaga Iscar, María Luisa
Taboada Martínez, Lara María Tamargo Chamorro.
Hospital de Urduliz Alfredo Espinosa. Urdúliz
María Aparicio López, Asier Aranguren Arostegui, Paula Arriola Martínez, Gorka Arroita Gonzalez,
Mª Soledad Azcona Losada, Miriam García Gómez, Eduardo Garcia Lopez, Amalur Iza Jiménez,
Alazne Lartategi Iraurgi, Esther Martinez Becerro, Itziar Oriñuela González, Isabel María Portales
Fernández, Pablo Ramirez Sánchez, Beatriz Ruiz Estévez, Cristian Vidal Núñez.
H. Virgen de la Salud. Toledo

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626

Ana Maria Alguacil Muñoz, Marta Blanco Fernández, Veronica Cano, Ricardo Crespo Moreno,
Fernando Cuadra Garcia-Tenorio, Blanca Díaz-Tendero Nájera, Raquel Estévez González, María Paz
García Butenegro, Alberto Gato Díez, Verónica Gómez Caverzaschi, Piedad María Gómez Pedraza,
Julio González Moraleja, Raúl Hidalgo Carvajal, Patricia Jiménez Aranda, Raquel Labra González,
Áxel Legua Caparachini, Pilar Lopez Castañeyra, Agustín Lozano Ancin, Jose Domingo Martin
Garcia, Cristina Morata Romero, María Jesús Moya Saiz, Helena Moza Moríñigo, Gemma Muñiz
Nicolás, Enriqueta Muñoz Platon, Filomena Oliveri, Elena Ortiz Ortiz, Raúl Perea Rafael, Pilar
Redondo Galán, María Antonia Sepulveda Berrocal, Vicente Serrano Romero de Ávila, Pilar
Toledano Sierra, Yamilex Urbano Aranda, Jesús Vázquez Clemente, Carmen Yera Bergua.
Hospital Regional Universitario de Málaga. Málaga
Mª Mar Ayala Gutiérrez, Rosa Bernal López, José Bueno Fonseca, Verónica Andrea Buonaiuto, Luis
Francisco Caballero Martínez, Lidia Cobos Palacios, Clara Costo Muriel, Francis de Windt, Ana
Teresa Fernandez-Truchaud Christophel, Paula García Ocaña, Ricardo Gómez Huelgas, Javier
Gorospe García, Maria Dolores López Carmona, Pablo López Quirantes, Almudena López Sampalo,
Elizabeth Lorenzo Hernández, Juan José Mancebo Sevilla, Jesica Martin Carmona, Luis Miguel
Pérez-Belmonte, Araceli Pineda Cantero, Michele Ricci, Jaime Sanz Cánovas
H. Santa Marina. Bilbao
Maria Areses Manrique, Ainara Coduras Erdozain, Ane Elbire Labirua-Iturburu Ruiz.
Hospital HLA Moncloa. Madrid
Teresa Garcia Delange, Isabel Jimenez Martinez, Carmen Martinez Cilleros, Nuria Parra Arribas.
H. del Henares. Coslada
Jesús Ballano Rodríguez-Solís, Luis Cabeza Osorio, María del Pilar Fidalgo Montero, Mª Isabel
Fuentes Soriano, Erika Esperanza Lozano Rincon, Ana Martín Hermida, Jesus Martinez Carrilero,
Jose Angel Pestaña Santiago, Manuel Sánchez Robledo, Patricia Sanz Rojas, Nahum Jacobo Torres
Yebes, Vanessa Vento.
H. U. Torrevieja. Torrevieja
Julio César Blázquez Encinar, Joaquín Fernández López-Cuervo.
H. U. La Fe. Valencia
Dafne Cabañero, María Calabuig Ballester, Pascual Císcar Fernández, Ricardo Gil Sánchez, Marta
Jiménez Escrig, Cristina Marín Amela, Laura Parra Gómez, Carlos Puig Navarro, José Antonio
Todolí Parra.
H. San Pedro. Logroño
Diana Alegre González, Irene Ariño Pérez de Zabalza, Sergio Arnedo Hernández, Jorge Collado
Sáenz, Beatriz Dendariena, Marta Gómez del Mazo, Iratxe Martínez de Narvajas Urra, Sara Martínez
Hernández, Estela Menendez Fernández, Jose Luís Peña Somovilla, Elisa Rabadán Pejenaute.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668

Hospital Universitario Ntra Sra Candelaria. Santa Cruz de Tenerife
Lucy Abella, Andrea Afonso Díaz, Selena Gala Aguilera Garcia, Marta Bethencourt Feria, Eduardo
Mauricio Calderón Ledezma, Sara Castaño Perez, Guillermo Castro Gainett, José Manuel del Arco
Delgado, Joaquín Delgado Casamayor, Diego Garcia Silvera, Alba Gómez Hidalgo, Marcelino
Hayek Peraza, Carolina Hernández Carballo, Rubén Hernández Luis, Francisco Javier Herrera
Herrera, Maria del Mar Lopez Gamez, Julia Marfil Daza, María José Monedero Prieto, María Blanca
Monereo Muñoz, María de la Luz Padilla Salazar, Daniel Rodríguez Díaz, Alicia Tejera, Laura Torres
Hernández.
H. U. San Juan de Alicante. San Juan de Alicante
David Balaz, David Bonet Tur, Pedro Jesús Esteve Atiénzar, Carles García Cervera, David Francisco
García Núñez, Vicente Giner Galvañ, Angie Gómez Uranga, Javier Guzmán Martínez, Isidro
Hernández Isasi, Lourdes Lajara Villar, Juan Manuel Núñez Cruz, Sergio Palacios Fernández, Juan
Jorge Peris García, Andrea Riaño Pérez, José Miguel Seguí Ripoll, Philip Wikman-Jorgensen.
H. U. San Agustin. Avilés
Andrea Álvarez García, Víctor Arenas García, Alba Barragán Mateos, Demelsa Blanco Suárez, María
Caño Rubia, Jaime Casal Álvarez, David Castrodá Copa, José Ferreiro Celeiro, Natalia García
Arenas, Raquel García Noriega, Joaquin Llorente García, Irene Maderuelo Riesco, Paula Martinez
Garcia, Maria Jose Menendez Calderon, Diego Eduardo Olivo Aguilar, Marta Nataya Solís
Marquínez, Luis Trapiella Martínez, Andrés Astur Treceño García, Juan Valdés Bécares.
H. de Mataró. Mataró
Raquel Aranega González, Ramon Boixeda, Carlos Lopera Mármol, Marta Parra Navarro, Ainhoa
Rex Guzmán, Aleix Serrallonga Fustier.
H. U. Son Llàtzer. Palma de Mallorca
Andrés de la Peña Fernández, Almudena Hernández Milián.
H. Juan Ramón Jiménez. Huelva
Francisco Javier Bejarano Luque, Francisco Javier Carrasco-Sánchez, Mercedes de Sousa Baena,
Jaime Díaz Leal, Aurora Espinar Rubio, Maria Franco Huertas, Juan Antonio García Bravo,
Andrés Gonzalez Macías, Encarnación Gutiérrez Jiménez, Alicia Hidalgo Jiménez, Constantino
Lozano Quintero, Carmen Mancilla Reguera, Francisco Javier Martínez Marcos, Francisco Muñoz
Beamud, Maria Perez Aguilera, Alícia Perez Jiménez, Virginia Rodríguez Castaño, Alvaro Sánchez
de Alcazar del Río, Leire Toscano Ruiz.
H. U. Reina Sofía. Córdoba
Antonio Pablo Arenas de Larriva, Pilar Calero Espinal, Javier Delgado Lista, María Jesús Gómez
Vázquez, Jose Jiménez Torres, Laura Martín Piedra, Javier Pascual Vinagre, María Elena Revelles
Vílchez, Juan Luis Romero Cabrera, José David Torres Peña.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710

Hospital Infanta Margarita. Cabra
María Esther Guisado Espartero, Lorena Montero Rivas, Maria de la Sierra Navas Alcántara,
Raimundo Tirado-Miranda.
H. U. Virgen de las Nieves. Granada
Pablo Conde Baena, Joaquin Escobar Sevilla, Laura Gallo Padilla, Patricia Gómez Ronquillo, Pablo
González Bustos, María Navío Botías, Jessica Ramírez Taboada, Mar Rivero Rodríguez.
Hospital Costa del Sol. Marbella
Victoria Augustín Bandera, María Dolores Martín Escalante.
Complejo Asistencial Universitario de León. León
Rosario Maria García Diez, Manuel Martin Regidor, Angel Luis Martínez Gonzalez, Alberto Muela
Molinero, Raquel Rodríguez Díez, Beatriz Vicente Montes.
Hospital Marina Baixa. Villajoyosa
Javier Ena, Jose Enrique Gómez Segado.
C. H. U. de Ferrol. Ferrol
Hortensia Alvarez Diaz, Tamara Dalama Lopez, Estefania Martul Pego, Carmen Mella Pérez, Ana
Pazos Ferro, Sabela Sánchez Trigo, Dolores Suarez Sambade, Maria Trigas Ferrin, Maria del Carmen
Vázquez Friol, Laura Vilariño Maneiro.
Hospital Torrecárdenas. Almería
Luis Felipe Díez García, Iris El Attar Acedo, Bárbara Hernandez Sierra, Carmen Mar Sánchez Cano.
Hospital Clinic Barcelona. Barcelona
Júlia Calvo Jiménez, Aina Capdevila Reniu, Irene Carbonell De Boulle, Emmanuel Coloma Bazán,
Joaquim Fernández Solà, Cristina Gabara Xancó, Joan Ribot Grabalosa, Olga Rodríguez Núñez.
Hospital del Tajo. Aranjuez
Ruth Gonzalez Ferrer, Raquel Monsalvo Arroyo.
Hospital Insular de Gran Canaria. Las Palmas G. C.
Marina Aroza Espinar, Jorge Orihuela Martín, Carlos Jorge Ripper, Selena Santana Jiménez.
H. U. Severo Ochoa. Leganés
Yolanda Casillas Viera, Lucía Cayuela Rodríguez, Carmen de Juan Alvarez, Gema Flox Benitez,
Laura García Escudero, Juan Martin Torres, Patricia Moreira Escriche, Susana Plaza Canteli, M
Carmen Romero Pérez.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752

Hospital Alto Guadalquivir. Andújar
Begoña Cortés Rodríguez.
Hospital Valle del Nalón. Riaño (Langreo)
Sara Fuente Cosío, César Manuel Gallo Álvaro, Julia Lobo García, Antía Pérez Piñeiro.
H. Francesc de Borja. Gandia
Alba Camarena Molina, Simona Cioaia, Anna Ferrer Santolalia, José María Frutos Pérez, Eva Gil
Tomás, Leyre Jorquer Vidal, Marina Llopis Sanchis, M Ángeles Martínez Pascual, Alvaro Navarro
Batet, Mari Amparo Perea Ribis, Ricardo Peris Sanchez, José Manuel Querol Ribelles, Silvia
Rodriguez Mercadal, Ana Ventura Esteve.
H. U. del Vinalopó. Elche
Francisco Amorós Martínez, Erika Ascuña Vásquez, Jose Carlos Escribano Stablé, Adriana
Hernández Belmonte, Ana Maestre Peiró, Raquel Martínez Goñi, M. Carmen Pacheco Castellanos,
Bernardino Soldan Belda, David Vicente Navarro.
H. G. U. de Castellón. Castellón de la Plana
Jorge Andrés Soler, Marián Bennasar Remolar, Alejandro Cardenal Álvarez, Daniela Díaz Carlotti,
María José Esteve Gimeno, Sergio Fabra Juana, Paula García López, María Teresa Guinot Soler,
Daniela Palomo de la Sota, Guillem Pascual Castellanos, Ignacio Pérez Catalán, Celia Roig Martí,
Paula Rubert Monzó, Javier Ruiz Padilla, Nuria Tornador Gaya, Jorge Usó Blasco.
C. H. U. de Badajoz. Badajoz
Rafael Aragon Lara, Inmaculada Cimadevilla Fernandez, Juan Carlos Cira García, Gema Maria
García García, Julia Gonzalez Granados, Beatriz Guerrero Sánchez, Francisco Javier Monreal
Periáñez, Maria Josefa Pascual Perez.
H. Santa Bárbara. Soria
Marta Leon Tellez.
C. A. U. de Salamanca. Salamanca
Gloria María Alonso Claudio, Víctor Barreales Rodríguez, Cristina Carbonell Muñoz, Adela Carpio
Pérez, María Victoria Coral Orbes, Daniel Encinas Sánchez, Sandra Inés Revuelta, Miguel Marcos
Martín, José Ignacio Martín González, José Ángel Martín Oterino, Leticia Moralejo Alonso, Sonia
Peña Balbuena, María Luisa Pérez García, Ana Ramon Prados, Beatriz Rodríguez-Alonso, Ángela
Romero Alegría, Maria Sanchez Ledesma, Rosa Juana Tejera Pérez.
H. U. Quironsalud Madrid. Pozuelo de Alarcón (Madrid)
Pablo Guisado Vasco, Ana Roda Santacruz, Ana Valverde Muñoz.
H. U. de Canarias. Santa Cruz de Tenerife

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794

Julio Cesar Alvisa Negrin, José Fernando Armas González, Lourdes González Navarrete, Iballa
Jiménez, María Candelaria Martín González, Esther Martín Ponce, Miguel Nicolas Navarrete Lorite,
Paula Ortega Toledo, Onán Pérez Hernández, Alina Pérez Ramírez.
H. U. del Sureste. Arganda del Rey
Jon Cabrejas Ugartondo, Ana Belén Mancebo Plaza, Arturo Noguerado Asensio, Bethania Pérez
Alves, Natalia Vicente López.
H. de Poniente. Almería
Juan Antonio Montes Romero, Encarna Sánchez Martín, Jose Luis Serrano Carrillo de Albornoz,
Manuel Jesus Soriano Pérez.
H. Parc Tauli. Sabadell
Francisco Epelde, Isabel Torrente
H. San Pedro de Alcántara. Cáceres
Angela

Agea Garcia, Javier Galán González, Luis Gámez Salazar, Eva Garcia Sardon, Antonio

González Nieto, Itziar Montero Díaz, Selene Núñez Gaspar, Alvaro Santaella Gomez.
H. de Pozoblanco. Pozoblanco
José Nicolás Alcalá Pedrajas, Antonia Márquez García, Inés Vargas.
H. Virgen de los Lirios. Alcoy (Alicante)
Mª José Esteban Giner.
Hospital Doctor José Molina Orosa. Arrecife (Lanzarote)
Virginia Herrero García, Berta Román Bernal.
Hospital de Palamós. Palamós
Maricruz Almendros Rivas, Miquel Hortos Alsina, Anabel Martin-Urda Diez-Canseco.
Hospital Clínico Universitario de Valladolid. Valladolid
Xjoylin Teresita Egües Torres, Sara Gutiérrez González, Cristina Novoa Fernández, Pablo Tellería
Gómez.
H. U. Puerta del Mar. Cádiz
José Antonio Girón González, Susana Fabiola Pascual Perez, Cristina Rodríguez Fernández-Viagas,
Maria José Soto Cardenas.
Hospìtal de Montilla. Montilla
Ana Cristina Delgado Zamorano, Beatriz Gómez Marín, Adrián Montaño Martínez, Jose Luis
Zambrana García.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.14.20193995; this version posted September 15, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

795
796
797
798
799
800
801
802
803
804
805
806
807
808

H. Infanta Elena. Huelva
María Gloria Rojano Rivero.
H. Virgen del Mar. Madrid
Thamar Capel Astrua, Paola Tatiana Garcia Giraldo, Maria Jesus Gonzalez Juarez, Victoria Marquez
Fernandez, Ada Viviana Romero Echevarry.
Hospital do Salnes. Vilagarcía de Arousa
Vanesa

Alende Castro, Ana María Baz Lomba, Ruth Brea Aparicio, Marta Fernandez Morales,

Jesus Manuel Fernandez Villar, Maria Teresa Lopez Monteagudo, Cristina Pérez García, Lorena
María Rodríguez Ferreira, Diana Sande Llovo, Maria Begoña Valle Feijoo.

